BioForce Nanosciences Current Ratio vs. Total Debt
| BFNH Stock | USD 1.09 0.00 0.00% |
For BioForce Nanosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioForce Nanosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioForce Nanosciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioForce Nanosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioForce Nanosciences Holdings over time as well as its relative position and ranking within its peers.
BioForce |
BioForce Nanosciences Total Debt vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. BioForce Nanosciences Holdings is rated below average in current ratio category among its peers. It is rated below average in total debt category among its peers making up about 15,687,000 of Total Debt per Current Ratio. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioForce Total Debt vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
BioForce Nanosciences |
| = | 0.01 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
BioForce Nanosciences |
| = | 156.87 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
BioForce Total Debt vs Competition
BioForce Nanosciences Holdings is rated below average in total debt category among its peers. Total debt of Packaged Foods industry is currently estimated at about 3.05 Billion. BioForce Nanosciences adds roughly 156,870 in total debt claiming only tiny portion of equities listed under Packaged Foods industry.
BioForce Nanosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioForce Nanosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioForce Nanosciences will eventually generate negative long term returns. The profitability progress is the general direction of BioForce Nanosciences' change in net profit over the period of time. It can combine multiple indicators of BioForce Nanosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
BioForce Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioForce Nanosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioForce Nanosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioForce Nanosciences' important profitability drivers and their relationship over time.
Use BioForce Nanosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioForce Nanosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioForce Nanosciences will appreciate offsetting losses from the drop in the long position's value.BioForce Nanosciences Pair Trading
BioForce Nanosciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to BioForce Nanosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioForce Nanosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioForce Nanosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioForce Nanosciences Holdings to buy it.
The correlation of BioForce Nanosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioForce Nanosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioForce Nanosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioForce Nanosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioForce Nanosciences position
In addition to having BioForce Nanosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Transportation Thematic Idea Now
Transportation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Transportation theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Transportation Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioForce Pink Sheet
To fully project BioForce Nanosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioForce Nanosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioForce Nanosciences' income statement, its balance sheet, and the statement of cash flows.